title: Topical application of liposomal cobalamin hydrogel for atopic dermatitis therapy.
abstract: Topical vitamin B12 was shown to be effective for atopic dermatitis. However, vitamin B12 itself is light sensitive and has low skin permeability, thus reducing its therapeutic effectiveness. In the present study, we prepared a liposomal hydrogel of adenosylcobalamin (AdCbl), a vitamin B12 derivative, and investigated possible beneficial effects of AdCbl on atopic dermatitis using an NC/Nga murine atopic dermatitis model. AdCbl was loaded into liposomes prepared by a thin film hydration method using a pH gradient method that employed citric acid buffer solution. This resulted in AdCbl-loaded liposomes that were 106.4 +/- 2.2 nm in size. The loading efficiency was 40% (of the initial AdCbl amount). Lipo-AdCbl had enhanced skin permeability, being about 17-fold compared with AdCbl-gel. Topical administration of Lipo-AdCbl-gel to 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis-like skin lesions in NC/Nga mice ameliorated lesion intensity scores, dorsal skin thickness, and total serum IgE in a concentration-dependent manner. Other preparations, including AdCbl solution, AdCbl cream, liposomes alone, and a mixture of AdCbl solution and liposomes had little effect. Taken together, our findings indicate that Lipo-AdCbl-gel has protective effects against atopic dermatitis symptoms, and suggest that it may be of benefit in the treatment of human inflammatory skin diseases.
authors.affiliation: Korea Research Institute of Chemical Technology, Daejeon, Korea.
authors.forename: Suk Hyun
authors.initials: SH
authors.lastname: Jung
authors.forename: Young Sik
authors.initials: YS
authors.lastname: Cho
authors.forename: Sung Soo
authors.initials: SS
authors.lastname: Jun
authors.forename: Ja Seong
authors.initials: JS
authors.lastname: Koo
authors.forename: Hyae Gyeong
authors.initials: HG
authors.lastname: Cheon
authors.forename: Byung Cheol
authors.initials: BC
authors.lastname: Shin
mesh_terms: D000287:Administration, Topical; D000818:Animals; D002021:Buffers; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000473:pathology; D015194:Diffusion Chambers, Culture; D004137:Dinitrochlorobenzene; D004337:Drug Carriers; D005260:Female; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D020100:Hydrogels; D006863:Hydrogen-Ion Concentration; D007073:Immunoglobulin E / Q000097:blood; D066298:In Vitro Techniques; D007509:Irritants; D008081:Liposomes; D051379:Mice; D008807:Mice, Inbred BALB C; D010316:Particle Size; D010539:Permeability; D012867:Skin / Q000473:pathology; D012869:Skin Absorption; D014805:Vitamin B 12 / Q000008:administration & dosage* / Q000627:therapeutic use*
chemical_list: D002021:Buffers; D004137:Dinitrochlorobenzene; D004337:Drug Carriers; D020100:Hydrogels; D007509:Irritants; D008081:Liposomes; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D007073:Immunoglobulin E; D014805:Vitamin B 12